高级检索
当前位置: 首页 > 详情页

DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

机构: [1]Institute of Cancer Research, Shenzhen Bay Laboratory, 518132 Shenzhen, China [2]Hepato-Biliary Surgery Division, Shenzhen Third People’s Hospital, TheSecond Affiliated Hospital, Southern University of Science and Technology, 518100 Shenzhen, China [3]Thoracic Surgical Department, Shenzhen ThirdPeople’s Hospital, The Second Affiliated Hospital, Southern University of Science and Technology, 518100 Shenzhen, China [4]Molecular Cancer ResearchCenter, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, 518107 Shenzhen, China [5]Department of Liver Surgery andLiver Transplant Center, West China Hospital of Sichuan University, 610041 Chengdu, China [6]Department of Liver Surgery, Peking Union Medical CollegeHospital, PUMC and Chinese Academy ofMedical Sciences, 100730 Beijing, Dongcheng, China [7]Department of Biochemistry, School ofMedicine, SouthernUniversity of Science and Technology, 518055 Shenzhen, China [8]BGI-Shenzhen, 518083 Shenzhen, China [9]School of Medicine, South China University ofTechnology, 510006 Guangzhou, Guangdong, China
出处:
ISSN:

摘要:
Plasma cell-free DNA (cfDNA) are small molecules generated through a non-random fragmentation procedure. Despite commendable translational values in cancer liquid biopsy, however, the biology of cfDNA, especially the principles of cfDNA fragmentation, remains largely elusive. Through orientation-aware analyses of cfDNA fragmentation patterns against the nucleosome structure and integration with multidimensional functional genomics data, here we report a DNA methylation - nuclease preference - cutting end - size distribution axis, demonstrating the role of DNA methylation as a functional molecular regulator of cfDNA fragmentation. Hence, low-level DNA methylation could increase nucleosome accessibility and alter the cutting activities of nucleases during DNA fragmentation, which further leads to variation in cutting sites and size distribution of cfDNA. We further develop a cfDNA ending preference-based metric for cancer diagnosis, whose performance has been validated by multiple pan-cancer datasets. Our work sheds light on the molecular basis of cfDNA fragmentation towards broader applications in cancer liquid biopsy.© 2023. The Author(s).

语种:
高被引:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 综合性期刊
小类 | 1 区 综合性期刊
最新[2023]版:
大类 | 1 区 综合性期刊
小类 | 1 区 综合性期刊
JCR分区:
出版当年[2023]版:
Q1 MULTIDISCIPLINARY SCIENCES
最新[2023]版:
Q1 MULTIDISCIPLINARY SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Institute of Cancer Research, Shenzhen Bay Laboratory, 518132 Shenzhen, China
通讯作者:
通讯机构: [8]BGI-Shenzhen, 518083 Shenzhen, China [9]School of Medicine, South China University ofTechnology, 510006 Guangzhou, Guangdong, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号